These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 16876524

  • 1. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
    Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M.
    Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524
    [Abstract] [Full Text] [Related]

  • 2. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 3. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [Abstract] [Full Text] [Related]

  • 5. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 6. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
    Degenring RF, Jonas JB.
    Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006
    [No Abstract] [Full Text] [Related]

  • 9. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.
    Potter MJ, Szabo SM, Ho T.
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):639-41. PubMed ID: 16175378
    [Abstract] [Full Text] [Related]

  • 10. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [Abstract] [Full Text] [Related]

  • 11. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS.
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [Abstract] [Full Text] [Related]

  • 13. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    Neovascular Age-Related Macular Degeneration, Periocular Corticosteroids, and Photodynamic Therapy (NAPP) Trial Research GroupJohns Hopkins University, Baltimore, Maryland, USA., Gilson MM, Bressler NM, Jabs DA, Solomon SD, Thorne JE, Wilson DJ.
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [Abstract] [Full Text] [Related]

  • 14. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Retina; 2005 Sep; 25(6):685-90. PubMed ID: 16141854
    [Abstract] [Full Text] [Related]

  • 15. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.
    Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
    [Abstract] [Full Text] [Related]

  • 16. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization.
    Hussain N, Das T, Rawal H, Kallukuri SB, Mohan Ram LS, Khanna R.
    Indian J Ophthalmol; 2006 Dec; 54(4):247-50. PubMed ID: 17090876
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.
    Retina; 2006 Dec; 26(6):602-12. PubMed ID: 16829800
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.
    Maberley D, Canadian Retinal Trials Group.
    Ophthalmology; 2009 Nov; 116(11):2149-57.e1. PubMed ID: 19748675
    [Abstract] [Full Text] [Related]

  • 20. Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injection.
    Luttrull JK, Spink CJ.
    Retina; 2007 Nov; 27(6):688-92. PubMed ID: 17621176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.